Active Pharmacovigilance in COVID-19 Patients: The Role of a Clinical Pharmacist in the Reporting of Adverse Drug Events

被引：0
|
作者：
Hida, A. [1 ,2 ]
Faroudy, M. [1 ,3 ]
Chaibi, A. [1 ,2 ]
Cadi, M. A. E. [1 ,2 ]
机构：
[1] Mohamed V Souissi Univ, Fac Med & Pharm Rabat, Rabat, Morocco
[2] Ibn Sina Univ Hosp, Dept Pharm, Rabat, Morocco
[3] Ibn Sina Univ Hosp, Intens Care Unit, Emergency Trauma Dept, Rabat, Morocco
来源：
DRUG SAFETY | 2022年 / 45卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P158
引用
收藏
页码：1200 / 1200
页数：1
相关论文
共 50 条
  • [21] Identification of Drug Interaction Adverse Events in Patients With COVID-19 A Systematic Review
    Conti, Valeria
    Sellitto, Carmine
    Torsiello, Martina
    Manzo, Valentina
    De Bellis, Emanuela
    Stefanelli, Berenice
    Bertini, Nicola
    Costantino, Maria
    Maci, Chiara
    Raschi, Emanuel
    Sabbatino, Francesco
    Corbi, Graziamaria
    Pagliano, Pasquale
    Filippelli, Amelia
    JAMA NETWORK OPEN, 2022, 5 (04) : E227970
  • [22] Hypoalbuminemia and clinical adverse events in children with COVID-19
    Loffredo, Lorenzo
    Campana, Andrea
    Olivini, Nicole
    Cotugno, Nicola
    Palma, Paolo
    Oliva, Alessandra
    Salvatori, Guglielmo
    Zicari, Anna Maria
    Violi, Francesco
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (05) : 2611 - 2613
  • [23] Stimulated Reporting of Adverse Events Following Immunization with COVID-19 Vaccines
    Jhaj, Ratinder
    Chaudhary, Deepa
    Shukla, Ajay K.
    Yadav, Jayanthi
    VACCINES, 2022, 10 (12)
  • [24] Spontaneous reporting of adverse drug events by Korean Regional Pharmacovigilance Centers
    Shin, Yoo Seob
    Lee, Yong-Won
    Choi, Young Hwa
    Park, Byungjoo
    Jee, Young Koo
    Choi, Sung-Kyu
    Kim, Eung-Gyu
    Park, Jung-Won
    Hong, Chein-Soo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (10) : 910 - 915
  • [25] Adverse drug events in the prevention and treatment of COVID-19: A data mining study on the FDA adverse event reporting system
    Guo, Qiang
    Duan, Shaojun
    Liu, Yaxi
    Yuan, Yinxia
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] Adverse drug reactions in patients with COVID-19
    Ferreira-da-Silva, Renato
    CADERNOS DE SAUDE PUBLICA, 2021, 37 (11):
  • [27] Pregnancy associated adverse events in patients treated with therapies for COVID-19 reported to the FDA ACMT COVID-19 ToxIC (FACT) pharmacovigilance project
    Simon, Mark
    Buchanan, Jennie
    Brent, Jeffrey
    Wax, Paul
    Burkhart, Keith
    Aldy, Kim
    CLINICAL TOXICOLOGY, 2022, 60 : 18 - 18
  • [28] The perspective of pharmacist on pharmacovigilance and adverse drug reaction reporting in Asir region, Saudi Arabia
    Alghazwani, Y.
    Alqahtani, A. M.
    Alshuraymi, M. K.
    Assiri, I. M.
    Shuflut, A. A.
    Krishnaraju, V.
    Kumarappan, C.
    Ibrahim, A. R. N.
    Orayj, K.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (04) : 1667 - 1680
  • [29] Adverse drug reactions in patients with COVID-19 in Brazil: analysis of spontaneous notifications of the Brazilian pharmacovigilance system
    Rabelo Melo, Jose Romerio
    Duarte, Elisabeth Carmen
    de Moraes, Marcelo Vogler
    Fleck, Karen
    do Nascimento e Silva, Amanda Soares
    Dourado Arrais, Paulo Sergio
    CADERNOS DE SAUDE PUBLICA, 2021, 37 (01):
  • [30] Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
    Shrestha, Sunil
    Khatri, Januka
    Shakya, Sujyoti
    Danekhu, Krisha
    Khatiwada, Asmita Priyadarshini
    Sah, Ranjit
    Bhuvan, K. C.
    Paudyal, Vibhu
    Khanal, Saval
    Rodriguez-Morales, Alfonso J.
    DRUGS & THERAPY PERSPECTIVES, 2021, 37 (08) : 376 - 382
12345